Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Cipla
Express Scripts
Chinese Patent Office
Boehringer Ingelheim
Federal Trade Commission
Medtronic
Colorcon
Cerilliant
Healthtrust

Generated: August 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087946

« Back to Dashboard
NDA 087946 describes ISOSORBIDE DINITRATE, which is a drug marketed by Sun Pharm Inds, Sun Pharm Inds Inc, Sandoz, Impax Labs Inc, Par Pharm, Watson Labs Teva, Watson Labs, Hikma Intl Pharms, and Superpharm, and is included in thirty-one NDAs. It is available from twenty-four suppliers. Additional details are available on the ISOSORBIDE DINITRATE profile page.

The generic ingredient in ISOSORBIDE DINITRATE is isosorbide dinitrate. There are thirty-seven drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.

Summary for NDA: 087946

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 087946

Ingredient-typeNitrates
Physiological EffectVasodilation

Suppliers and Packaging for NDA: 087946

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ISOSORBIDE DINITRATE
isosorbide dinitrate
TABLET;ORAL 087946 ANDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-7584 0615-7584-39 30 TABLET in 1 BLISTER PACK (0615-7584-39)
ISOSORBIDE DINITRATE
isosorbide dinitrate
TABLET;ORAL 087946 ANDA AvKARE, Inc. 42291-350 42291-350-01 100 TABLET in 1 BOTTLE (42291-350-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength30MG
Approval Date:Jan 12, 1988TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
QuintilesIMS
Queensland Health
Argus Health
McKesson
Accenture
Fish and Richardson
Citi
Deloitte
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot